Ebola vaccines appear safe and successful, say US researchers

Two experimental Ebola vaccinations “appear to be safe” after testing in Liberia. Meanwhile, a British nurse has been cleared of the virus, but doctors cautioned speculation about the drug’s role in her recovery. The two vaccines, one from GlaxoSmithKline and the other from biotech start-up NewLink Genetics, “appear to be safe,” the US National Institutes of Health (NIH) said. The single injection vaccines proved safe for 600 participants, Fatorma Bolay from the Partnership for Research on Ebola Vaccines in Liberia said. “We are grateful to the Liberian people who volunteered for this important clinical trial and encouraged by the study results,” NIAID Director Dr Anthony Fauci said in a statement. “Now we must move forward to adapt and expand the study so that ultimately we can determine whether these experimental vaccines can protect against [the] Ebola virus disease and therefore be used in future Ebola outbreaks,” Fauci added. The trial began on February 2,...